SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells

• Published in: The FASEB journal 2019-03, Vol.33 (3), p.3704-3717
• Main Authors: Sociali, Giovanna, Grozio, Alessia, Caffa, Irene, Schuster, Susanne, Becherini, Pamela, Damonte, Patrizia, Sturla, Laura, Fresia, Chiara, Passalacqua, Mario, Mazzola, Francesca, Raffaelli, Nadia, Garten, Antje, Kiess, Wieland, Cea, Michele, Nencioni, Alessio, Bruzzone, Santina
• Format: Article
• Language: English
• Subjects: Cell Line; Cell Line, Tumor; Cytokines - metabolism; Doxorubicin - pharmacology; Glucosephosphate Dehydrogenase - metabolism; HEK293 Cells; Hep G2 Cells; Humans; Hydrogen Peroxide - pharmacology; MCF-7 Cells; NADP - metabolism; Neoplasms - drug therapy; Neoplasms - metabolism; nicotinamide adenine dinucleotide; nicotinamide phosphoribosyltransferase; Nicotinamide Phosphoribosyltransferase - metabolism; Oxidative Stress - drug effects; Oxidative Stress - physiology; Poly(ADP-ribose) Polymerases - metabolism; Sirtuin 6; Sirtuins - metabolism; Up-Regulation - drug effects; Up-Regulation - physiology
• ISSN: 0892-6638; 1530-6860
• DOI: 10.1096/fj.201800321R

ABSTRACT Nicotinamide phosphoribosyltransferase (NAMPT) is the rate‐limiting enzyme in the NAD+ salvage pathway from nicotinamide. By controlling the biosynthesis of NAD+, NAMPT regulates the activity of NAD+‐converting enzymes, such as CD38, poly‐ADP‐ribose polymerases, and sirtuins (SIRTs). SIRT6 is involved in the regulation of a wide number of metabolic processes. In this study, we investigated the ability of SIRT6 to regulate intracellular NAMPT activity and NAD(P)(H) levels. BxPC‐3 cells and MCF‐7 cells were engineered to overexpress a catalytically active or a catalytically inactive SIRT6 form or were engineered to silence endogenous SIRT6 expression. In SIRT6‐overexpressing cells, NAD(H) levels were up‐regulated, as a consequence of NAMPT activation. By immunopurification and incubation with recombinant SIRT6, NAMPT was found to be a direct substrate of SIRT6 deacetylation, with a mechanism that upregulates NAMPT enzymatic activity. Extracellular NAMPT release was enhanced in SIRT6‐silenced cells. Also glucose‐6‐phosphate dehydrogenase activity and NADPH levels were increased in SIRT6‐overexpressing cells. Accordingly, increased SIRT6 levels reduced cancer cell susceptibility to H2O2‐induced oxidative stress and to doxorubicin. Our data demonstrate that SIRT6 affects intracellular NAMPT activity, boosts NAD(P)(H) levels, and protects against oxidative stress. The use of SIRT6 inhibitors, together with agents inducing oxidative stress, may represent a promising treatment strategy in cancer.—Sociali, G., Grozio, A., Caffa, I., Schuster, S., Becherini, P., Damonte, P., Sturla, L., Fresia, C., Passalacqua, M., Mazzola, F., Raffaelli, N., Garten, A., Kiess, W., Cea, M., Nencioni, A., Bruzzone, S. SIRT6 deacetylase activity regulates NAMPT activity and NAD(P)(H) pools in cancer cells. FASEB J. 33, 3704–3717 (2019). www.fasebj.org